Oracle's Stock Set for Recovery with Price Target of $210.72
Oracle has experienced a dramatic decline of nearly 40% over the past year, yet it has been quietly building a backlog that exceeds its annual revenue. With a critical earnings date approaching, the stock is poised for either a breakout or a further setback. Recently, Oracle's stock price rebounded by 25.89% in the past month as investors reassess its backlog, which now stands at $638 billion in AI contracts. This recovery has led analysts at 24/7 Wall St. to set a price target of $210.72 for Oracle, suggesting a potential upside of 45.56% from its current trading price of $144.76. The analysts express a high level of confidence in this target, rating it as a buy with a 90% confidence level.
Despite the recent uptick, Oracle's stock is still down 25.01% year to date and 37.80% over the past year, primarily due to concerns about the company's spending on AI capabilities. Retail sentiment turned bearish earlier this month, particularly regarding Larry Ellison's 346 million shares pledged as collateral for loans. However, sentiment has shifted to a more bullish outlook recently.
For Your Trading Desk
Sponsor Spike Success.
The turning point for Oracle came with its Q4 FY2026 report, which revealed a revenue of $19.184 billion and earnings per share of $2.11. The company also reported a staggering 93% growth in its OCI segment and disclosed $67 billion in AI infrastructure contracts signed during the quarter. The upcoming Q1 FY2027 results, scheduled for September 10, are highly anticipated by investors.
The bullish case for Oracle is supported by its remaining performance obligations (RPO) backlog of $638 billion, which has increased by 363%. This backlog provides Oracle with multi-year revenue visibility that few software companies can match. CEO Safra Catz has reaffirmed expectations of a revenue compound annual growth rate (CAGR) of over 31% and an EPS CAGR of over 28% through fiscal year 2030.
In the most recent quarter, Oracle's multicloud database revenue surged by 404%, and GPU utilization reached 97.5%. The management aims for a margin profile of 30% to 40% at steady state for OCI. If Oracle's data center expansion proceeds as planned, the stock could reach $349.71 within the next twelve months.
However, Oracle's free cash flow was negative $23.68 billion in FY26, with capital expenditures of $55.66 billion and total liabilities of $218.70 billion. The company plans to raise approximately $40 billion in debt and equity in FY27, which includes a $20 billion ATM equity program that could exert downward pressure on the stock price. Additionally, software license revenue declined by 6% in Q4.
Supporters of Oracle argue that the company's spending is largely financed by $75 billion in prepaid or customer-supplied GPU arrangements, which management claims will not negatively impact margins. The bear case still sees Oracle's stock price at $178.42, which is above its current trading price.
Oracle's forward price-to-earnings ratio stands at 18x, significantly lower than the implied multiple suggested by analysts. Comparatively, Microsoft, which competes with Oracle's OCI on AI workloads, has seen its stock rise by 2.32% year to date, highlighting the market's preference for scale and profitability. Salesforce, another competitor, trades at a higher P/E ratio of 23 with an operating margin of 21%.
Despite the challenges, Oracle's FY27 revenue guidance of $90 billion indicates strong growth potential. The upcoming earnings report on September 10 will be crucial in confirming the company's growth trajectory, particularly in the cloud segment, which is projected to grow between 58% and 64%. The outlook could weaken if the equity raise occurs sooner or is larger than anticipated. Overall, the projections hinge on Oracle's ability to execute its growth plans and manage its capital effectively, with significant upside or downside risks tied to GPU supply and data center ramp timing.




